Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington’s disease
Authors:
Open Access
- 12 April 2024
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121 (16)
Abstract
Many Mendelian disorders, such as Huntington’s disease (HD) and spinocerebellar ataxias, arise from expansions of CAG trinucleotide repeats. Despite the clear genetic causes, additional genetic factors may influence the rate of those monogenic disorders. Notably, genome-wide association studies discovered somewhat expected modifiers, particularly mismatch repair genes involved in the CAG repeat instability, impacting age at onset of HD. Strikingly, FAN1 , previously unrelated to repeat instability, produced the strongest HD modification signals. Diverse FAN1 haplotypes independently modify HD, with rare genetic variants diminishing DNA binding or nuclease activity of the FAN1 protein, hastening HD onset. However, the mechanism behind the frequent and the most significant onset-delaying FAN1 haplotype lacking missense variations has remained elusive. Here, we illustrated that a microRNA acting on 3′-UTR (untranslated region) SNP rs3512, rather than transcriptional regulation, is responsible for the significant FAN1 expression quantitative trait loci signal and allelic imbalance in FAN1 messenger ribonucleic acid (mRNA), accounting for the most significant and frequent onset-delaying modifier haplotype in HD. Specifically, miR-124-3p selectively targets the reference allele at rs3512, diminishing the stability of FAN1 mRNA harboring that allele and consequently reducing its levels. Subsequent validation analyses, including the use of antagomir and 3′-UTR reporter vectors with swapped alleles, confirmed the specificity of miR-124-3p at rs3512. Together, these findings indicate that the alternative allele at rs3512 renders the FAN1 mRNA less susceptible to miR-124-3p-mediated posttranscriptional regulation, resulting in increased FAN1 levels and a subsequent delay in HD onset by mitigating CAG repeat instability.Keywords
Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS105709)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS119471)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS091161)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS125742)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS049206)
This publication has 61 references indexed in Scilit:
- Genetic modifiers of Huntington disease differentially influence motor and cognitive domainsThe American Journal of Human Genetics, 2022
- Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier EffectsThe American Journal of Human Genetics, 2020
- A genetic variant within MDM4 3′UTR miRNA binding site is associated with HPV16‐positive tumors and survival of oropharyngeal cancerMolecular Carcinogenesis, 2019
- Dynamic Modulation of Microglia/Macrophage Polarization by miR-124 after Focal Cerebral IschemiaJournal of Neuroimmune Pharmacology, 2016
- DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseasesAnnals of Neurology, 2016
- MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradationActa Neuropathologica, 2013
- Gene Dysregulation in Huntington’s Disease: REST, MicroRNAs and BeyondNeuroMolecular Medicine, 2009
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brainsNeurobiology of Disease, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993